Impact of Continuous Glucose Monitoring and Education Intervention on Glycemic Control and Behavioral Changes in Pre-Diabetic Adolescents
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: FitBit and continuous glucose monitoring.
- Who it may be relevant to
- Registry conditions: Pre Diabetes. Basic parameters: 13 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Pilot Study Evaluating the Impact of Continuous Glucose Monitoring and Education Intervention on Glycemic Control and Behavioral Changes in Pre-Diabetic Adolescents
Overview
Prediabetes is a condition wherein blood sugar levels are elevated but not sufficiently high enough to diagnose type 2 diabetes mellitus (T2D). Prediabetes is a critical risk factor for the development of T2D in pediatric populations. This progression can occur over a short period of time, limiting the efficacy and impact of existing interventions and recommendations targeting this population. There is growing evidence on the use of continuous glucose monitors (CGMs) in adult prediabetic populations to prevent the development of T2D, though this intervention has not been thoroughly investigated in pediatric populations. The investigators are proposing a pilot study of 25 prediabetic adolescents enrolled in a 20-week study. For the initial 10 weeks of the study, the participants will go without CGMs and undergo clinically recommended education on their condition as standard of care. In the 10 weeks following, participants will be given a CGM to wear and instructions on its use. Surveys will be issued to all participants over the entirety of the study to follow behaviors surrounding food and physical activity.
Interventions
- Device FitBit and continuous glucose monitoring
The purpose of this pilot study is to evaluate the effectiveness of CGMs in assisting prediabetic adolescents to make appropriate lifestyle changes aimed at preventing the development of T2D. The investigators hypothesize that the use of CGMs over 10 weeks will result in beneficial lifestyle changes, relative to a period without CGM. The investigators will evaluate beneficial lifestyle changes by following eating habits, physical activity levels, and biometric measurements
Primary outcome measures
- Behavioral Changes as measured by questionnaires [Time frame: 20 weeks]
Secondary outcome measures (2)
- Physical Activity [Time frame: From enrollment to the end of the study at 20 weeks]
- Height, weight and BMI [Time frame: From enrollment to the end of the study at 20 weeks]
Eligibility criteria
Inclusion criteria
- • At least 13 years of age
- No older than 17 years of age (up to 18th birthday)
- Access to a smart-device compatible with a continuous glucose monitor application and wearable biosensor
- Diagnosed prediabetes, defined as any of the following:
- Fasting plasma glucose of 100- 125 mg/dL
- 2-hour glucose level on oral glucose tolerance test (OGTT):140-199 mg/dL
- HbA1c 5.7%-6.4%
Exclusion criteria
- • Previous diagnosis of Prader Willi Syndrome
- Previous diagnosis of hypothalamic obesity
- Previous diagnosis of intellectual disability
- Previous or planned bariatric surgery
- Current use of medication is known to impact weight
- Previous diagnosis of diabetes mellitus
- Hemoglobin A1c >6.5%
- Non-English speaking
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07569185 · STUDY00007226